A detailed history of 180 Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, 180 Wealth Advisors, LLC holds 8,966 shares of AMGN stock, worth $2.44 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
8,966
Previous 9,054 0.97%
Holding current value
$2.44 Million
Previous $2.92 Million 19.92%
% of portfolio
0.37%
Previous 0.46%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

SELL
$258.78 - $328.31 $22,772 - $28,891
-88 Reduced 0.97%
8,966 $2.34 Million
Q3 2024

Oct 31, 2024

BUY
$309.38 - $337.38 $19,800 - $21,592
64 Added 0.71%
9,054 $2.92 Million
Q2 2024

Jul 16, 2024

BUY
$262.75 - $319.31 $1.84 Million - $2.24 Million
7,013 Added 354.73%
8,990 $2.81 Million
Q1 2024

Apr 15, 2024

SELL
$268.87 - $324.56 $2,957 - $3,570
-11 Reduced 0.55%
1,977 $562,000
Q4 2023

Jan 24, 2024

SELL
$255.7 - $288.46 $22,245 - $25,096
-87 Reduced 4.19%
1,988 $572,000
Q3 2023

Oct 31, 2023

SELL
$218.65 - $271.46 $3,935 - $4,886
-18 Reduced 0.86%
2,075 $557,000
Q2 2023

Jul 11, 2023

BUY
$214.27 - $253.37 $21,212 - $25,083
99 Added 4.96%
2,093 $464,000
Q1 2023

Apr 07, 2023

SELL
$225.79 - $275.2 $4,741 - $5,779
-21 Reduced 1.04%
1,994 $482,000
Q4 2022

Feb 02, 2023

BUY
$229.03 - $291.01 $66,876 - $84,974
292 Added 16.95%
2,015 $529,000
Q3 2022

Oct 12, 2022

SELL
$224.46 - $253.15 $11,223 - $12,657
-50 Reduced 2.82%
1,723 $388,000
Q2 2022

Jul 11, 2022

SELL
$230.71 - $256.74 $922 - $1,026
-4 Reduced 0.23%
1,773 $435,000
Q1 2022

Apr 22, 2022

SELL
$219.27 - $242.57 $37,714 - $41,722
-172 Reduced 8.83%
1,777 $450,000
Q4 2021

Jan 26, 2022

SELL
$198.88 - $227.6 $124,300 - $142,250
-625 Reduced 24.28%
1,949 $444,000
Q3 2021

Oct 28, 2021

BUY
$212.27 - $248.7 $100,828 - $118,132
475 Added 22.63%
2,574 $535,000
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $2,802 - $3,109
-12 Reduced 0.57%
2,099 $478,000
Q1 2021

May 25, 2021

SELL
$221.91 - $258.6 $24,853 - $28,963
-112 Reduced 5.04%
2,111 $530,000
Q4 2020

Jan 27, 2021

BUY
$216.38 - $257.67 $31,158 - $37,104
144 Added 6.93%
2,223 $552,000
Q3 2020

Oct 23, 2020

BUY
$234.65 - $260.95 $703 - $782
3 Added 0.14%
2,079 $480,000
Q2 2020

Jul 21, 2020

SELL
$197.81 - $242.74 $21,561 - $26,458
-109 Reduced 4.99%
2,076 $536,000
Q1 2020

Apr 09, 2020

SELL
$182.24 - $241.7 $6,742 - $8,942
-37 Reduced 1.67%
2,185 $456,000
Q4 2019

Jan 17, 2020

SELL
$189.21 - $243.2 $31,408 - $40,371
-166 Reduced 6.95%
2,222 $537,000
Q3 2019

Oct 22, 2019

SELL
$174.11 - $208.62 $157,221 - $188,383
-903 Reduced 27.44%
2,388 $479,000
Q2 2019

Aug 05, 2019

SELL
$166.7 - $195.41 $21,337 - $25,012
-128 Reduced 3.74%
3,291 $612,000
Q1 2019

May 14, 2019

SELL
$180.87 - $203.88 $81,572 - $91,949
-451 Reduced 11.65%
3,419 $594,000
Q4 2018

Jan 15, 2019

SELL
$178.4 - $208.25 $18,196 - $21,241
-102 Reduced 2.57%
3,870 $802,000
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $1,482 - $1,671
-8 Reduced 0.2%
3,972 $823,000
Q2 2018

Aug 08, 2018

BUY
$166.05 - $186.51 $328,280 - $368,730
1,977 Added 98.7%
3,980 $735,000
Q1 2018

Jun 01, 2018

SELL
$169.43 - $198.0 $1 Million - $1.17 Million
-5,919 Reduced 74.72%
2,003 $345,000
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $1.34 Million - $1.49 Million
7,922
7,922 $1.38 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track 180 Wealth Advisors, LLC Portfolio

Follow 180 Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 180 Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 180 Wealth Advisors, LLC with notifications on news.